For comorbid metabolic diseases, such as diabetes and obesity, the use of GLP-1RAs generally does not increase cancer risk and may offer certain benefits
This app-based, provider-led approach can also help members lose weight by tailoring their medication needs, including GLP-1 drugs
however, some patients may still not achieve metabolic targets and efficacy remains considerably less than that seen with bariatric surgery
They will determine the appropriate transition plan and equivalent dosing to ensure a smooth and effective switch from one delivery method to another
Learn about the provider here: Final thoughts Heres the thing, oral GLP-1 drops are an important option in the expanding field of medical weight management
If the only reason someone ever went to the gym was to lose weight, that relationship with exercise can become pretty fragile because the moment weight loss happens through another pathway, the motivation disappears